Urinary excretion kinetics of [177Lu]Lu-PSMA-617

• Published in: European journal of nuclear medicine and molecular imaging Vol. 50; no. 12; pp. 3572 - 3575
• Main Authors: de Bakker, Maarten, Dominicus, Noa, Meeuwis, Antoi, Janssen, Marcel, Konijnenberg, Mark W., Nagarajah, James, Peters, Steffie M. B.
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.10.2023; Springer Nature B.V
• Subjects: Cardiology; Contamination; Excretion; Imaging; Kinetics; Lutetium isotopes; Medicine; Medicine & Public Health; Nuclear Medicine; Oncology; Orthopedics; Prostate cancer; Radiation; Radiation measurement; Radiology; Safety measures; Scintillation counters; Short Communication; Urine; Waste management; Therapy; PSMA; Excretion kinetics; Radiation safety
• ISSN: 1619-7070; 1619-7089
• DOI: 10.1007/s00259-023-06328-8

Introduction For the implementation of suitable radiation safety measures in [ 177 Lu]Lu-PSMA-617 therapy, additional insight into excretion kinetics is important. This study evaluates this kinetics in prostate cancer patients via direct urine measurements. Methods Both the short-term (up to 24 h, n  = 28 cycles) and long-term kinetics (up to 7 weeks, n  = 35 samples) were evaluated by collection of urine samples. Samples were measured on a scintillation counter to determine excretion kinetics. Results The mean excretion half-time during the first 20 h was 4.9 h. Kinetics was significantly different for patients with kidney function below or above eGFR 65 ml/min. Calculated skin equivalent dose in case of urinary contamination was between 50 and 145 mSv when it was caused between 0 and 8 h p.i.. Measurable amounts of 177 Lu were found in urine samples up to 18 days p.i.. Conclusion Excretion kinetics of [ 177 Lu]Lu-PSMA-617 is especially relevant during the first 24 h, when accurate radiation safety measures are important to prevent skin contamination. Measures for accurate waste management are relevant up to 18 days.